Picture of United Laboratories International Holdings logo

3933 United Laboratories International Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

Annual cashflow statement for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,2032,0073,3443,2892,528
Depreciation
Amortisation
Non-Cash Items21558.7-38.6-162-116
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-495-587-1,432-543689
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,5432,0312,4393,1993,750
Capital Expenditures-482-818-1,411-1,870-2,894
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-105224-146142729
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-587-595-1,557-1,728-2,165
Financing Cash Flow Items-41.3-33.7-42.314.746.5
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-621-24.2-1,3635972,780
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3341,412-4812,0684,277